$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs

$nhhs Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000150370723000006 Filed on March 27, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$49.57M		$185.1M
YoY Change	14.39%		-23.9%
Cost Of Revenue	$35.08M		$137.6M
YoY Change	6.64%		-22.68%
Gross Profit	$14.49M		$47.56M
YoY Change	38.83%		-27.22%
Gross Profit Margin	29.23%		25.69%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$9.649M		$38.59M
YoY Change	-2.76%		-29.63%
% of Gross Profit	66.59%		81.14%
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$11.36M		$43.28M
YoY Change	10.19%		-29.77%
% of Operating Profit
Other Income/Expense, Net	$132.0K		$77.00K
YoY Change	83.33%		-98.94%
Pretax Income	-$10.06M		-$102.1M
YoY Change	-34.96%		-1021.91%
Income Tax	$15.00K		$61.00K
% Of Pretax Income
Net Earnings	-$14.00M		-$54.50M
YoY Change	7.83%		-303.25%
Net Earnings / Revenue	-28.24%		-29.44%
Basic Earnings Per Share	-$0.07		-$0.28
Diluted Earnings Per Share	-$0.07		-$0.28
COMMON SHARES
Basic Shares Outstanding	195.4M shares	195.3M shares	194.3M shares
Diluted Shares Outstanding	195.4M shares		194.3M shares

Balance Sheet

Concept	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$95.57M	$103.9M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles	$2.169M	$2.253M
YoY Change	-13.45%	-13.01%
Long-Term Investments	$171.5M	$176.5M
YoY Change	-17.33%	-16.87%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.218B	$1.238B
YoY Change	-12.43%	-12.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$929.6M	$936.8M
YoY Change	-2.64%	-3.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.443B	-$1.429B
YoY Change	11.79%	11.83%
Common Stock	$1.732B	$1.732B
YoY Change	0.36%	0.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$286.3M	$299.0M
YoY Change
Total Liabilities & Shareholders Equity	$1.218B	$1.238B
YoY Change	-12.43%	-12.39%

Cashflow Statement

Concept	2023 Q1	2022
OPERATING ACTIVITIES
Net Income	-$14.00M	-$54.50M
YoY Change	7.83%	-303.25%
Depreciation, Depletion And Amortization	$9.649M	$38.59M
YoY Change	-2.76%	-29.63%
Cash From Operating Activities	-$3.536M	$7.824M
YoY Change	-67.39%	-221.53%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$523.0K	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$818.0K	$15.54M
YoY Change	-117.35%	-97.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$4.828M	-$118.6M
YoY Change	12.36%	-77.95%
NET CHANGE
Cash From Operating Activities	-$3.536M	$7.824M
Cash From Investing Activities	-$818.0K	$15.54M
Cash From Financing Activities	-$4.828M	-$118.6M
Net Change In Cash	-$9.182M	-$95.28M
YoY Change	-11.91%	-181.18%
FREE CASH FLOW
Cash From Operating Activities	-$3.536M	$7.824M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001503707
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#RealEstateInvestmentPropertyNet
CY2022Q4	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilities
CY2022	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#GainLossOnInvestments
CY2021	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#GainLossOnInvestments
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	7338000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	2019000	usd
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	3064000	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	0	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	195421665	shares
CY2022	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2022	dei	Auditor Location AuditorLocation	New York, New York
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	200473000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	10465000	usd
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	972599000	usd
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	469000	usd
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	195421665	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	195421665	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	193120940	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	193120940	shares
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3679000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-486000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	299024000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	444475000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	2048000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	2343000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	301072000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	446818000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1237835000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1412873000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	44274000	usd
CY2022	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	139841000	usd
CY2022	us-gaap	Other Operating Income OtherOperatingIncome	1021000	usd
CY2022	us-gaap	Revenues Revenues	185136000	usd
CY2022	us-gaap	Interest Income Debt Securities Operating InterestIncomeDebtSecuritiesOperating	0	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	137578000	usd
CY2022	us-gaap	Interest Expense InterestExpense	43278000	usd
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1569000	usd
CY2022	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	8058000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13938000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-401000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-54100000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-54100000	usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	194343635	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	189573204	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	189573204	shares
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.50
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	49872	shares
CY2022	us-gaap	Profit Loss ProfitLoss	-54501000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	26815000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3193000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-953000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3193000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-953000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-57694000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	25862000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-401000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1748000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-57293000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	24114000	usd
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	667504000	usd
CY2020	nshi	Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees	9685000	usd
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	169000	usd
CY2020	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	234000	usd
CY2020	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	151000	usd
CY2020	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	2078000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	937000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-264238000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	412062000	usd
CY2021	nshi	Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees	10557000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	165000	usd
CY2021	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	724000	usd
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2552000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-953000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	26815000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	446818000	usd
CY2022	nshi	Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees	8866000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	28000	usd
CY2022	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	330000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	224000	usd
CY2022	us-gaap	Dividends Dividends	97052000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3193000	usd
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-34466000	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	65006000	usd
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	165968000	usd
CY2022	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	usd
CY2021	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	usd
CY2020	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	222000	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3247000	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3169000	usd
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3090000	usd
CY2022	us-gaap	Straight Line Rent StraightLineRent	0	usd
CY2021	us-gaap	Straight Line Rent StraightLineRent	-7803000	usd
CY2020	us-gaap	Straight Line Rent StraightLineRent	-441000	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	usd
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	697000	usd
CY2020	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	125000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	637000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1662000	usd
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1887000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	207000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	165000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	169000	usd
CY2022	nshi	Paid In Kind Interest Added To Real Estate Debt Investment Loan Principal PaidInKindInterestAddedToRealEstateDebtInvestmentLoanPrincipal	0	usd
CY2021	nshi	Paid In Kind Interest Added To Real Estate Debt Investment Loan Principal PaidInKindInterestAddedToRealEstateDebtInvestmentLoanPrincipal	194000	usd
CY2020	nshi	Paid In Kind Interest Added To Real Estate Debt Investment Loan Principal PaidInKindInterestAddedToRealEstateDebtInvestmentLoanPrincipal	0	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	1029000	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	79477000	usd
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	302000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	176000	usd
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2371000	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	8058000	usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	10557000	usd
CY2020	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	9685000	usd
CY2022	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	22291000	usd
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	usd
CY2020	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	usd
CY2022	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-332000	usd
CY2021	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-1756000	usd
CY2020	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	4233000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3644000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1287000	usd
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-4859000	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-5928000	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-985000	usd
CY2020	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	2853000	usd
CY2022	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	-90000	usd
CY2021	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	-2680000	usd
CY2020	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	559000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5222000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-17346000	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8479000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-602000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-254000	usd
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-139000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7824000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6438000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	31018000	usd
CY2022	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	29304000	usd
CY2021	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	27773000	usd
CY2020	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	15214000	usd
CY2022	nshi	Proceeds From Sale Of Real Estate Investing ProceedsFromSaleOfRealEstateInvesting	0	usd
CY2021	nshi	Proceeds From Sale Of Real Estate Investing ProceedsFromSaleOfRealEstateInvesting	596414000	usd
CY2020	nshi	Proceeds From Sale Of Real Estate Investing ProceedsFromSaleOfRealEstateInvesting	927000	usd
CY2020	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	0	usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	400000	usd
CY2020	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2020	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	5923000	usd
CY2020	nshi	Proceeds From Real Estate Debt Investment Modification Fee ProceedsFromRealEstateDebtInvestmentModificationFee	0	usd
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	51000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8415000	usd
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	20250000	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
CY2020	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	35000000	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	35000000	usd
CY2020	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	36000	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	708000	usd
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	8288000	usd
CY2020	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	480000	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	578000	usd
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	608000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2078000	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	97018000	usd
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	usd
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	usd
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	330000	usd
CY2021	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	724000	usd
CY2020	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	234000	usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	224000	usd
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2552000	usd
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	151000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-118640000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-538020000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12147000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-95278000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	117368000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	34750000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58820000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115660000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	210938000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	93570000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	38836000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	65828000	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	53140000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	53000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	100000	usd
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	10000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1227000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3624000	usd
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1779000	usd
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	112000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	100000	usd
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022	nshi	Noncash Or Part Noncash Transaction Reclassification Of Operating Real Estate To Assets Of Held For Sale NoncashOrPartNoncashTransactionReclassificationOfOperatingRealEstateToAssetsOfHeldForSale	0	usd
CY2021	nshi	Noncash Or Part Noncash Transaction Reclassification Of Operating Real Estate To Assets Of Held For Sale NoncashOrPartNoncashTransactionReclassificationOfOperatingRealEstateToAssetsOfHeldForSale	0	usd
CY2020	nshi	Noncash Or Part Noncash Transaction Reclassification Of Operating Real Estate To Assets Of Held For Sale NoncashOrPartNoncashTransactionReclassificationOfOperatingRealEstateToAssetsOfHeldForSale	5000000	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	Business and Organization<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NorthStar Healthcare Income, Inc., together with its consolidated subsidiaries (the “Company”), owns a diversified portfolio of seniors housing properties, including independent living facilities (“ILF”), assisted living (“ALF”) and memory care facilities (“MCF”) located throughout the United States. In addition, the Company also has made investments through non-controlling interests in joint ventures in a broader spectrum of healthcare real estate, including seniors housing properties, as well as continuing care retirement communities (“CCRC”), skilled nursing (“SNF”), medical office buildings (“MOB”), specialty hospitals and ancillary services businesses, across the United States and United Kingdom.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was formed in October 2010 as a Maryland corporation and commenced operations in February 2013. The Company elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”), commencing with the taxable year ended December 31, 2013. The Company has conducted its operations, and intends to do so in the future, so as to continue to qualify as a REIT for U.S. federal income tax purposes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s business is conducted through NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Company is the sole general partner of the Operating Partnership. The limited partners of the Operating Partnership are NorthStar Healthcare Income Advisor, LLC and NorthStar Healthcare Income OP Holdings, LLC (the “Special Unit Holder”). NorthStar Healthcare Income Advisor, LLC invested $1,000 in the Operating Partnership in exchange for common units and the Special Unit Holder invested $1,000 in the Operating Partnership and was issued a separate class of limited partnership units (the “Special Units”), which are collectively recorded as non-controlling interests on the accompanying consolidated balance sheets as of December 31, 2022 and December 31, 2021. As the Company issued shares, it contributed substantially all of the proceeds from its continuous, public offerings to the Operating Partnership as a capital contribution. As of December 31, 2022, the Company’s limited partnership interest in the Operating Partnership was 99.99%.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s charter authorizes the issuance of up to 400.0 million shares of common stock with a par value of $0.01 per share and up to 50.0 million shares of preferred stock with a par value of $0.01 per share. The board of directors of the Company is authorized to amend its charter, without the approval of the stockholders, to increase the aggregate number of authorized shares of capital stock or the number of shares of any class or series that the Company has authority to issue.</span></div><div style="margin-bottom:5pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From inception through December 31, 2022, the Company raised $2.0 billion in total gross proceeds from the sale of shares of common stock in its continuous, public offerings (the “Offering”), including $232.6 million pursuant to its distribution reinvestment plan (the “DRP”). </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Internalization</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From inception through October 21, 2022, the Company was externally managed by CNI NSHC Advisors, LLC or its predecessor (the “Former Advisor”), an affiliate of NRF Holdco, LLC (the “Former Sponsor”). The Former Advisor was responsible for managing the Company’s operations, subject to the supervision of the Company’s board of directors, pursuant to an advisory agreement. On October 21, 2022, the Company completed the internalization of the Company’s management function (the “Internalization”). In connection with the Internalization, the Company agreed with the Former Advisor to terminate the advisory agreement and arranged for the Former Advisor to continue to provide certain services for a transition period. Going forward, the Company will be self-managed under the leadership of Kendall Young, who was appointed by the board of directors as Chief Executive Officer and President concurrent with the Internalization.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of COVID-19</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's healthcare real estate business and investments have been challenged by suboptimal occupancy levels, lower labor force participation rates, which has driven increased labor costs, and inflationary pressures on other operating expenses.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These lasting effects from the response to the coronavirus 2019 (“COVID-19”) pandemic will continue to impact Company’s operational and financial performance. An extended recovery period increases the risk of a prolonged negative impact on the Company’s financial condition and results of operations. While the Company has the ability to meet its near term liquidity needs, general market concerns over credit and liquidity continue, and the effects of COVID-19 may also lead to heightened risk of litigation, with an ensuing increase in litigation and related costs.</span></div>At this time, the progression of the global economic recovery remains difficult for the Company to assess and estimate the future impact on the Company's results of operations. Accordingly, any estimates as reflected or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Annual Report on Form 10-K, and such estimates may change, the effects of which could be material. The Company will continue to monitor the progression of the economic recovery and reassess its effects on the Company’s results of operations and recoverability of value across its assets as conditions change.
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2000000000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that could affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates and assumptions. Any estimates of the effects of the COVID-19 pandemic, inflation, rising interest rates, risk of recession and other economic conditions as reflected and/or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Annual Report on Form 10-K. Such estimates may change and the impact of which could be material.</span></div>
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	103926000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	200473000	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65995000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	11734000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	10465000	usd
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	27575000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115660000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	210938000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	93570000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	500000	usd
CY2022	nshi	Finance Lease Payments FinanceLeasePayments	500000	usd
CY2021	nshi	Finance Lease Payments FinanceLeasePayments	700000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	97000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	60000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	29000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	24000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	18000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	10000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	238000	usd
CY2022Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	29000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	209000	usd
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.075
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M24D
CY2022Q4	nshi	Number Of Triple Net Lease Portfolios NumberOfTripleNetLeasePortfolios	4	portfolio
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	117896000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	117559000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2253000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2590000	usd
CY2022	nshi	Amortizationof Deferred Costsand Intangible Assets AmortizationofDeferredCostsandIntangibleAssets	300000	usd
CY2021	nshi	Amortizationof Deferred Costsand Intangible Assets AmortizationofDeferredCostsandIntangibleAssets	1400000	usd
CY2022Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year One DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearOne	337000	usd
CY2022Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Two DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	337000	usd
CY2022Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Three DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearThree	337000	usd
CY2022Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Four DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearFour	337000	usd
CY2022Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Five DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearFive	337000	usd
CY2022Q4	nshi	Deferred Costs And Finite Lived Intangible Assets Amortization Expense After Year Five DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	568000	usd
CY2022Q4	nshi	Deferred Costsand Finite Lived Intangible Assets Net DeferredCostsandFiniteLivedIntangibleAssetsNet	2253000	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-500000	usd
CY2022Q4	nshi	Lease Terms Days Notice Required For Termination LeaseTermsDaysNoticeRequiredForTermination	30	day
CY2022Q4	nshi	Lease Terms Days Notice Required For Termination LeaseTermsDaysNoticeRequiredForTermination	30	day
CY2022	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	11200000	usd
CY2021	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	13100000	usd
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	31900000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5400000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	15300000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	99000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53000	usd
CY2022Q4	us-gaap	Land Land	121518000	usd
CY2021Q4	us-gaap	Land Land	121518000	usd
CY2022Q4	us-gaap	Land Improvements LandImprovements	18945000	usd
CY2021Q4	us-gaap	Land Improvements LandImprovements	17798000	usd
CY2022Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	957924000	usd
CY2021Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	965630000	usd
CY2022Q4	us-gaap	Tenant Improvements TenantImprovements	372000	usd
CY2021Q4	us-gaap	Tenant Improvements TenantImprovements	0	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	6736000	usd
CY2021Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	8141000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	91058000	usd
CY2021Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	84813000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1196553000	usd
CY2021Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1197900000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	263551000	usd
CY2021Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	225301000	usd
CY2022Q4	us-gaap	Real Estate Investments RealEstateInvestments	933002000	usd
CY2021Q4	us-gaap	Real Estate Investments RealEstateInvestments	972599000	usd
CY2020	us-gaap	Depreciation Depreciation	63100000	usd
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	31900000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5400000	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	10919000	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	11192000	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	11472000	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	11759000	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	12053000	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	21792000	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	79187000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	176502000	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	212309000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	47625000	usd
CY2022	nshi	Proceeds From Equity Method Investment Distribution Operating And Investing Activities ProceedsFromEquityMethodInvestmentDistributionOperatingAndInvestingActivities	67133000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	15843000	usd
CY2021	nshi	Proceeds From Equity Method Investment Distribution Operating And Investing Activities ProceedsFromEquityMethodInvestmentDistributionOperatingAndInvestingActivities	18110000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	30256000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	19612000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	669466000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	46876000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	156145000	usd
CY2022Q4	nshi	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	0	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	922355000	usd
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	7338000	usd
CY2022	nshi	Related Party Transaction Dueto Related Parties Amount Incurred RelatedPartyTransactionDuetoRelatedPartiesAmountIncurred	17316000	usd
CY2022	nshi	Related Party Transaction Dueto Related Parties Amount Paid RelatedPartyTransactionDuetoRelatedPartiesAmountPaid	24185000	usd
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	469000	usd
CY2020Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	8318000	usd
CY2021	nshi	Related Party Transaction Dueto Related Parties Amount Incurred RelatedPartyTransactionDuetoRelatedPartiesAmountIncurred	25140000	usd
CY2021	nshi	Related Party Transaction Dueto Related Parties Amount Paid RelatedPartyTransactionDuetoRelatedPartiesAmountPaid	26120000	usd
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	7338000	usd
CY2021	nshi	Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issuedas Paymentfor Asset Management Fees NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedasPaymentforAssetManagementFees	10600000	usd
CY2022	nshi	Stock Redeemedor Called During Period Shares Paymentof Advisor Asset Management Fees StockRedeemedorCalledDuringPeriodSharesPaymentofAdvisorAssetManagementFees	2300000	shares
CY2022	nshi	Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issuedas Paymentfor Asset Management Fees NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedasPaymentforAssetManagementFees	8900000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	206917	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	230083	usd
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	168917	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	211250	usd
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	223167	usd
CY2022Q2	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.50
CY2022Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	97100000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	226500000	usd
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-400000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1700000	usd
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2800000	usd
CY2022	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	1000000	usd
CY2022	nshi	Rentaland Resident Fee Income RentalandResidentFeeIncome	185136000	usd
CY2022	us-gaap	Interest Income Operating InterestIncomeOperating	0	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	137578000	usd
CY2022	us-gaap	Interest Expense InterestExpense	43278000	usd
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1569000	usd
CY2022	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	8058000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13938000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	38587000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	45299000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	77000	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	1029000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	47625000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-54501000	usd
CY2021	nshi	Rentaland Resident Fee Income RentalandResidentFeeIncome	243277000	usd
CY2021	us-gaap	Interest Income Operating InterestIncomeOperating	4667000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	177936000	usd
CY2021	us-gaap	Interest Expense InterestExpense	61620000	usd
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	54000	usd
CY2021	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	11105000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12691000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	54836000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5386000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7278000	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	79477000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	15843000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	99000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	26815000	usd
CY2020	nshi	Rentaland Resident Fee Income RentalandResidentFeeIncome	275348000	usd
CY2020	us-gaap	Interest Income Operating InterestIncomeOperating	7674000	usd
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	184178000	usd
CY2020	us-gaap	Interest Expense InterestExpense	65991000	usd
CY2020	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	65000	usd
CY2020	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	17170000	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16505000	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	65006000	usd
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	165968000	usd
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1840000	usd
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	302000	usd
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-34466000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-264238000	usd
CY2022Q4	us-gaap	Assets Assets	1237835000	usd
CY2021Q4	us-gaap	Assets Assets	1412873000	usd
CY2022Q4	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	56	property
CY2022Q4	us-gaap	Number Of Units In Real Estate Property NumberOfUnitsInRealEstateProperty	6840	unit
CY2022	us-gaap	Noninterest Income NoninterestIncome	185136000	usd
CY2022Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	500000	usd
CY2020Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	291041000	usd
CY2022Q4	srt	Real Estate Federal Income Tax Basis RealEstateFederalIncomeTaxBasis	1500000	usd
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1197900000	usd
CY2020Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1774971000	usd
CY2019Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1931032000	usd
CY2022	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	0	usd
CY2021	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	603082000	usd
CY2020	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	0	usd
CY2022	us-gaap	Real Estate Improvements RealEstateImprovements	30531000	usd
CY2021	us-gaap	Real Estate Improvements RealEstateImprovements	31397000	usd
CY2020	us-gaap	Real Estate Improvements RealEstateImprovements	17036000	usd
CY2022	us-gaap	Sec Schedule Iii Real Estate Writedown Or Reserve Amount SECScheduleIIIRealEstateWritedownOrReserveAmount	31878000	usd
CY2021	us-gaap	Sec Schedule Iii Real Estate Writedown Or Reserve Amount SECScheduleIIIRealEstateWritedownOrReserveAmount	5386000	usd
CY2020	us-gaap	Sec Schedule Iii Real Estate Writedown Or Reserve Amount SECScheduleIIIRealEstateWritedownOrReserveAmount	165246000	usd
CY2022Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Gross Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateGrossIncludingHeldForSale	1196553000	usd
CY2021Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Gross Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateGrossIncludingHeldForSale	1197900000	usd
CY2020Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Gross Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateGrossIncludingHeldForSale	1782822000	usd
CY2022Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateClassifiedAsHeldForSale	0	usd
CY2021Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateClassifiedAsHeldForSale	0	usd
CY2020Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateClassifiedAsHeldForSale	7851000	usd
CY2022Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1196553000	usd
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1197900000	usd
CY2020Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	1774971000	usd
CY2022Q4	nshi	Sec Schedule Iii Real Estate Amountof Federal Income Tax Basis Over Cost Basis SECScheduleIIIRealEstateAmountofFederalIncomeTaxBasisOverCostBasis	349400000	usd
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	225301000	usd
CY2020Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	291041000	usd
CY2019Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	230814000	usd
CY2022	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	38250000	usd
CY2021	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	53476000	usd
CY2020	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	63078000	usd
CY2022	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	0	usd
CY2021	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	119216000	usd
CY2020	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	0	usd
CY2022Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationIncludingHeldForSale	263551000	usd
CY2021Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationIncludingHeldForSale	225301000	usd
CY2020Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Including Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationIncludingHeldForSale	293892000	usd
CY2022Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationClassifiedAsHeldForSale	0	usd
CY2021Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationClassifiedAsHeldForSale	0	usd
CY2020Q4	nshi	Sec Schedule1228 Real Estate Companies Investment In Real Estate Accumulated Depreciation Classified As Held For Sale SECSchedule1228RealEstateCompaniesInvestmentInRealEstateAccumulatedDepreciationClassifiedAsHeldForSale	2851000	usd
CY2022Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	263551000	usd
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	225301000	usd
CY2021Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	0	usd
CY2020Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	55864000	usd
CY2019Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	55468000	usd
CY2022	nshi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate New Mortgage Loan Capitalized Payment In Kind Interest SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateNewMortgageLoanCapitalizedPaymentInKindInterest	0	usd
CY2021	nshi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate New Mortgage Loan Capitalized Payment In Kind Interest SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateNewMortgageLoanCapitalizedPaymentInKindInterest	194000	usd
CY2020	nshi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate New Mortgage Loan Capitalized Payment In Kind Interest SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateNewMortgageLoanCapitalizedPaymentInKindInterest	0	usd
CY2022	nshi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Loan Modification Fees SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateLoanModificationFees	0	usd
CY2021	nshi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Loan Modification Fees SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateLoanModificationFees	687000	usd
CY2020	nshi	Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Loan Modification Fees SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateLoanModificationFees	0	usd
CY2022	nshi	Sec Schedule1229 Real Estate Companies Investmentin Mortgage Loanson Real Estate Reclassification SECSchedule1229RealEstateCompaniesInvestmentinMortgageLoansonRealEstateReclassification	0	usd
CY2021	nshi	Sec Schedule1229 Real Estate Companies Investmentin Mortgage Loanson Real Estate Reclassification SECSchedule1229RealEstateCompaniesInvestmentinMortgageLoansonRealEstateReclassification	-18307000	usd
CY2020	nshi	Sec Schedule1229 Real Estate Companies Investmentin Mortgage Loanson Real Estate Reclassification SECSchedule1229RealEstateCompaniesInvestmentinMortgageLoansonRealEstateReclassification	-271000	usd
CY2022	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	0	usd
CY2021	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	74376000	usd
CY2020	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	0	usd
CY2022	us-gaap	Mortgage Loans On Real Estate Amortization Of Premium MortgageLoansOnRealEstateAmortizationOfPremium	0	usd
CY2021	us-gaap	Mortgage Loans On Real Estate Amortization Of Premium MortgageLoansOnRealEstateAmortizationOfPremium	698000	usd
CY2020	us-gaap	Mortgage Loans On Real Estate Amortization Of Premium MortgageLoansOnRealEstateAmortizationOfPremium	125000	usd
CY2022Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	0	usd
CY2021Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	0	usd
CY2020Q4	us-gaap	Mortgage Loans On Real Estate MortgageLoansOnRealEstate	55864000	usd
CY2022	dei	Auditor Firm AuditorFirmId	248

Files In Submission

Name	View Source	Status
0001503707-23-000006-index-headers.html	Edgar Link	pending
0001503707-23-000006-index.html	Edgar Link	pending
0001503707-23-000006.txt	Edgar Link	pending
0001503707-23-000006-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nhi5tharindiedirectorscomp.htm	Edgar Link	pending
nshi-20221231.htm	Edgar Link	pending
nshi-20221231.xsd	Edgar Link	pending
nshi-20221231_g1.jpg	Edgar Link	pending
nshi-20221231_g2.jpg	Edgar Link	pending
nshi-20221231_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
nshi-20221231_def.xml	Edgar Link	unprocessable
nshi12312022exhibit211.htm	Edgar Link	pending
nshi12312022exhibit311.htm	Edgar Link	pending
nshi12312022exhibit312.htm	Edgar Link	pending
nshi12312022exhibit321.htm	Edgar Link	pending
nshi12312022exhibit322.htm	Edgar Link	pending
nshi12312022exhibit42.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
nshi-20221231_lab.xml	Edgar Link	unprocessable
nshi-20221231_htm.xml	Edgar Link	completed
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
trilogyreitholdingsllcfina.htm	Edgar Link	pending
tsaamno1-edgarversionex1015.htm	Edgar Link	pending
nshi-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs

2023 Q1 Form 10-K Financial Statement

#000150370723000006 Filed on March 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHHS NorthStar Healthcare Income, Inc. Stock $nhhs

2023 Q1 Form 10-K Financial Statement

#000150370723000006 Filed on March 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs